Nom du produit:4,5,6,7-tetradeuterio-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione

IUPAC Name:2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro(²H₄)-1H-isoindole-1,3-dione

CAS:1219177-18-0
Formule moléculaire:C13H6D4N2O4
Pureté:95%+
Numéro de catalogue:CM340807
Poids moléculaire:262.26

Unité d'emballage Stock disponible Prix($) Quantité
CM340807-10mg 5-6 Weeks ŢȎȎȎ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1219177-18-0
Formule moléculaire:C13H6D4N2O4
Point de fusion:-
Code SMILES:O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C([2H])=C([2H])C([2H])=C3[2H])=O
Densité:
Numéro de catalogue:CM340807
Poids moléculaire:262.26
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.